Marshall Wace, LLP Cerus Corp Transaction History
Marshall Wace, LLP
- $63.3 Billion
- Q1 2024
A detailed history of Marshall Wace, LLP transactions in Cerus Corp stock. As of the latest transaction made, Marshall Wace, LLP holds 202,578 shares of CERS stock, worth $445,671. This represents 0.0% of its overall portfolio holdings.
Number of Shares
202,578Holding current value
$445,671% of portfolio
0.0%Shares
7 transactions
Others Institutions Holding CERS
# of Institutions
152Shares Held
144MCall Options Held
39.6KPut Options Held
60.9K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl21.5MShares$47.4 Million0.29% of portfolio
-
Baker Bros. Advisors LP New York, NY19.5MShares$42.9 Million0.47% of portfolio
-
Black Rock Inc. New York, NY13.6MShares$30 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.98MShares$22 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA8.58MShares$18.9 Million0.01% of portfolio
About CERUS CORP
- Ticker CERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 177,090,000
- Market Cap $390M
- Description
- Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...